Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Total Debt: 2015-2019

Historic Total Debt for Outlook Therapeutics (OTLK) over the last 5 years, with Sep 2019 value amounting to $6.7 million.

  • Outlook Therapeutics' Total Debt fell 91.94% to $544,924 in Q2 2020 from the same period last year, while for Jun 2020 it was $544,924, marking a year-over-year decrease of 91.94%. This contributed to the annual value of $6.7 million for FY2019, which is 3991.29% up from last year.
  • As of FY2019, Outlook Therapeutics' Total Debt stood at $6.7 million, which was up 3,991.29% from $164,967 recorded in FY2018.
  • Outlook Therapeutics' 5-year Total Debt high stood at $13.3 million for FY2017, and its period low was $164,967 during FY2018.
  • Moreover, its 3-year median value for Total Debt was $6.7 million (2019), whereas its average is $6.7 million.
  • Per our database at Business Quant, Outlook Therapeutics' Total Debt slumped by 98.76% in 2018 and then soared by 3,991.29% in 2019.
  • Yearly analysis of 5 years shows Outlook Therapeutics' Total Debt stood at $3.7 million in 2015, then dropped by 23.06% to $2.8 million in 2016, then soared by 371.03% to $13.3 million in 2017, then tumbled by 98.76% to $164,967 in 2018, then soared by 3,991.29% to $6.7 million in 2019.